Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P220002/S011

TOPS System

Premia Spine, Ltd. · Decision date Sep 9, 2026

MEDTECHLEDGER EXPLANATIONP220002/S011

What did the FDA decide?

Premia Spine, Ltd. holds PMA P220002/S011 for the TOPS™ System, a posterior spinal element prosthesis (product code QWK, orthopedic specialty). The record describes this supplement as a 30-Day Notice for a process change involving a manufacturer, sterilizer, packager or supplier. The stated change is the addition of a subcontractor, Triangle Manufacturing Co., Inc., to manufacture pedicle screw components used with the TOPS™ implant.

FDA recorded the decision as OK30 on 2026-09-09. That action applies to the supplement and the subcontractor change it covers, not to a new approval of the full TOPS™ System. The source does not describe the pedicle screw specifications, the manufacturing processes affected, or any conditions attached to the decision, and no supporting documents are listed, so those details remain unknown.

Whether the added subcontractor affects component supply, traceability or post-market obligations cannot be determined from this record alone and would require the underlying FDA documents.

FDA approval order statement

addition of an additional subcontractor for the manufacturing of pedicle screw components to be used with the TOPS implant - Triangle Manufacturing Co., Inc.
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Orthopedic
Decision date
Sep 9, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P220002/S011
Regulatory pathway
PMA supplement
Product code
QWK
Decision code
OK30
Decision date
Sep 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, posterior spinal elements.

Product code
QWK
FDA device class
3

For the original device and its historical approval scope, see PMA P220002. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P220002/S011 received

    Application receipt date recorded by FDA.

  2. P220002/S011 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P220002. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P220002

Product / regulatory recordCompanyPathwayDecision dateSource
Premia Spine, Ltd.PMA approvalJun 15, 2023FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Premia Spine, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
7 Giborey Israel St., Ramat Poleg, Netanya, 4250407

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records